Peter A Schneider
Overview
Explore the profile of Peter A Schneider including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
113
Citations
888
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Powell R, Farber A, Doros G, Chew D, Conte M, Dake M, et al.
J Vasc Interv Radiol
. 2025 Feb;
PMID: 40015448
Purpose: To analyze the causes and clinical impacts of endovascular technical failure (ETF) in the BEST-CLI trial, which compared endovascular therapy to bypass surgery in patients with chronic limb-threatening ischemia...
2.
Flanagan C, Trang K, Nacario J, Schneider P, Gasper W, Conte M, et al.
J Vasc Surg
. 2024 Dec;
PMID: 39694151
Objective: Participation in the Vascular Quality Initiative (VQI) provides important resources to surgeons, but the ability to do so is often limited by time and data entry personnel. Large language...
3.
Pietzsch J, Geisler B, Garner A, Ryschon A, Gray W, Fujihara M, et al.
J Comp Eff Res
. 2024 Dec;
14(1):e240055.
PMID: 39620243
Percutaneous transluminal angioplasty (PTA) for peripheral artery disease (PAD) commonly leads to dissections which are associated with higher target lesion revascularization (TLR) rates. Clinical and economic consequences of dissection management...
4.
Brodmann M, Gray W, Schneider P, Kurzmann-Guetl K, Schweiger L, Zeller T, et al.
Eur J Vasc Endovasc Surg
. 2024 Nov;
69(3):452-462.
PMID: 39615582
Objective: The aim of the TRANSCEND study was to compare the safety and efficacy of the next generation SurVeil PCB with the IN.PACT Admiral PCB in patients with femoropopliteal arterial...
5.
Paraskevas K, AbuRahma A, Abularrage C, Clair D, Eldrup-Jorgensen J, Kashyap V, et al.
Ann Vasc Surg
. 2024 Oct;
110(Pt B):42-53.
PMID: 39413993
Background: Transcarotid artery revascularization (TCAR) has emerged as an alternative therapeutic modality to carotid endarterectomy (CEA) and transfemoral carotid artery stenting (TFCAS) for the management of patients with carotid artery...
6.
Menard M, Farber A, Doros G, McGinigle K, Chisci E, Clavijo L, et al.
J Vasc Surg
. 2024 Jul;
80(6):1755-1765.e4.
PMID: 39069016
Objective: Sustained clinical and hemodynamic benefit after revascularization for chronic limb-threatening ischemia (CLTI) is needed to resolve symptoms and prevent limb loss. We sought to compare rates of clinical and...
7.
Schneider P, Olin J
J Am Coll Cardiol
. 2024 Mar;
83(13):1222-1224.
PMID: 38538201
No abstract available.
8.
Why selective screening for asymptomatic carotid stenosis is currently appropriate: a special report
Paraskevas K, Dardik A, Schermerhorn M, Liapis C, Mansilha A, Lal B, et al.
Expert Rev Cardiovasc Ther
. 2024 Mar;
22(4-5):159-165.
PMID: 38480465
Introduction: Two of the main reasons recent guidelines do not recommend routine population-wide screening programs for asymptomatic carotid artery stenosis (AsxCS) is that screening could lead to an increase of...
9.
Liu I, El Khoury R, Hiramoto J, Gasper W, Schneider P, Vartanian S, et al.
J Vasc Surg
. 2024 Feb;
79(6):1438-1446.e2.
PMID: 38401777
Objective: Major adverse limb event-free survival (MALE-FS) differed significantly by initial revascularization approach in the BEST-CLI randomized trial. The BEST-CLI trial represented a highly selected subgroup of patients seen in...
10.
Secemsky E, Yeh R, Schneider P, Gray W, Parikh S
Am J Cardiol
. 2024 Feb;
216:43-45.
PMID: 38369174
No abstract available.